[FMS] Fresenius Medical Care Corporation

Overview

Type of security: Stock

Sector: Health Care

Industry: Hospital/Nursing Management

Market Capitalization: 26.66 B

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 42.4 Change: 0.06 (0.14%)
Ext. hours: Change: 0 (0%)

chart FMS

Refresh chart

Strongest Trends Summary For FMS

FMS is in the medium-term down -14% below S&P in 2 months. In the long-term down -39% below S&P in 2 years and up 280% in 22 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides renal dialysis products and services. It offers dialysis treatment, and related laboratory and diagnostic services through its network of 3,250 outpatient dialysis clinics in approximately 45 countries worldwide; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also provides pharmacy services, such as delivery and supply of renal medications to patients at homes or to dialysis clinics directly; vascular access surgery services; and manufactures and distributes products for the treatment of end-stage renal disease (ESRD). In addition, it offers laboratory services that include blood, urine, and other bodily fluid testing services; and hemodialysis (HD) m

Fundamental Ratios
Shares Outstanding610.73 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y-20.08% Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow28.67 ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-237.29 M Cash From Investing Activities-208.84 M Cash From Operating Activities447.27 M Gross Profit1.18 B
Net Profit209.55 M Operating Profit504.4 M Total Assets25.11 B Total Current Assets6.6 B
Total Current Liabilities3.55 B Total Debt9.05 B Total Liabilities15.56 B Total Revenue3.96 B
Technical Data
High 52 week53.37 Low 52 week31.1 Last close33.66 Last change0.21%
RSI18.62 Average true range0.76 Beta0.62 Volume94.68 K
Simple moving average 20 days-7.54% Simple moving average 50 days-10.64% Simple moving average 200 days-14.55%
Performance Data
Performance Week-1.69% Performance Month-15% Performance Quart-16.97% Performance Half3.31%
Performance Year-32.69% Performance Year-to-date3.92% Volatility daily1.9% Volatility weekly4.25%
Volatility monthly8.71% Volatility yearly30.18% Relative Volume258.11% Average Volume230.29 K
New High New Low

News

2019-09-09 11:02:00 | Global Insights and Local Promise: Fresenius Medical Care's annual medical report explores how Interconnected Intelligence is transforming healthcare

2019-09-06 00:13:38 | Should You Worry About Fresenius Medical Care AG & Co. KGaA's ETR:FME CEO Pay Cheque?

2019-09-05 11:23:24 | Huge Southaven laboratory could mean more than 300 jobs

2019-08-22 09:45:00 | CTSO: Q2 19: Product Sales Rebound to Record High Despite Distributor Hangover. Value-Inflection Opportunities Abound

2019-08-22 09:30:01 | Is Fresenius Medical FMS a Good Value Investor Pick Now?

2019-08-19 00:02:13 | Should You Be Impressed By Fresenius Medical Care AG & Co. KGaA's ETR:FME ROE?

2019-08-07 21:24:51 | Cytosorbents CTSO Q2 2019 Earnings Call Transcript

2019-08-06 11:47:03 | 3 Marijuana Stocks to Play the Future of Cannabis Medicine

2019-08-01 00:00:18 | What Should You Know About Fresenius Medical Care AG & Co. KGaA's ETR:FME Growth?

2019-07-31 19:00:33 | Edited Transcript of FME.DE earnings conference call or presentation 30-Jul-19 1:30pm GMT

2019-07-31 09:10:01 | Fresenius Medical FMS Q2 Earnings Miss Estimates, Down Y/Y

2019-07-30 18:23:44 | Fresenius Medical Care AG & Co. KGaA FMS Q2 2019 Earnings Call Transcript

2019-07-30 01:52:17 | UPDATE 1-Fresenius raises 2019 sales outlook after Q2 hits targets

2019-07-30 00:59:42 | Fresenius Medical Care confirms 2019 targets

2019-07-29 12:38:02 | 3 Large-Cap Stocks Offer High Earnings Yields

2019-07-29 04:15:00 | Celebrating Nurses: The Hearts and Souls of Fresenius Kidney Care

2019-07-18 00:02:55 | Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA ETR:FME?

2019-07-17 16:00:13 | CVS Health Tests Home Dialysis System; DaVita, Fresenius Hit

2019-07-17 08:00:00 | CVS enters home dialysis care with clinical trial of new system

2019-07-12 10:28:02 | The Zacks Analyst Blog Highlights: DaVita, Fresenius, Baxter, Amgen and CVS

2019-07-12 07:00:00 | Home Dialysis to Benefit These Undervalued Providers

2019-07-11 09:20:01 | Trump's Order on Kidney Care Lifts These Dialysis Stocks

2019-07-10 17:32:09 | Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others

2019-07-10 16:58:16 | Trump Calls for Overhaul of Costly Kidney Dialysis Program

2019-07-10 16:26:00 | Fresenius Medical Care sees U.S. plans for changes to kidney disease care as positive reinforcement of company's strategy

2019-07-10 15:05:26 | Trump's executive order on kidney health lifts dialysis company stocks

2019-07-10 09:58:10 | UPDATE 3-Trump administration pushes U.S. at-home kidney care, transplant availability

2019-07-10 00:38:43 | Trump Targets Dialysis, Kidney Transplants in Care Overhaul

2019-07-09 12:37:14 | Trump’s Next Phase on Health Care: Everywhere and Nowhere

2019-07-09 07:48:11 | Fresenius Set for Global Expansion of Research Activities

2019-07-09 07:12:00 | DaVita Lower as HHS Plans to Emphasize At-Home Dialysis Treatment

2019-07-02 07:16:00 | Better Buy: GW Pharmaceuticals vs. Cara Therapeutics

2019-06-30 02:14:34 | Does Fresenius Medical Care AG & Co. KGaA's ETR:FME Debt Level Pose A Problem?

2019-06-30 02:00:36 | Introducing Fresenius Medical Care KGaA ETR:FME, A Stock That Climbed 38% In The Last Five Years

2019-06-27 16:34:00 | These European companies benefit from high health-care prices in the U.S.

2019-06-07 17:11:08 | U.S. Renal Care, Inc New -- Moody's assigns a Caa2 rating to the senior unsecured notes of US Renal Care, Inc. NEW

2019-06-06 02:00:21 | INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?

2019-06-02 09:09:00 | Is Cara Therapeutics a Buy Now?

2019-05-30 12:28:07 | U.S. RENAL CARE, INC. NEW -- Moody's assigns a B3 CFR to US Renal Care, Inc. NEW; outlook stable

2019-05-30 07:48:11 | Cara Shares Up on Positive Phase III Data for Itchiness Drug

2019-05-29 13:00:00 | Fresenius Medical Care Breaks Ground on Knoxville Distribution Center

2019-05-23 13:52:08 | Fresenius Finance Ireland II Plc -- Moody's announces completion of a periodic review of ratings of Fresenius SE & Co. KGaA

2019-05-22 15:17:13 | Fresenius Medical Care US Finance II, Inc -- Moody's announces completion of a periodic review of ratings of Fresenius Medical Care Holdings, Inc.

2019-05-06 11:05:03 | Fresenius Medical FMS Q1 Earnings & Revenues Top Estimates

2019-05-02 15:24:26 | Edited Transcript of FME.DE earnings conference call or presentation 2-May-19 1:30pm GMT

2019-05-02 12:56:14 | Fresenius makes solid start to year after turbulent 2018

2019-04-18 14:57:10 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA  - FMS

2019-04-16 16:00:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

2019-04-12 13:40:45 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS

2019-04-02 13:19:22 | Fresenius Medical Care to pay $231M to resolve bribery charges